Product Program year 2024 Source: CMS Open Payments

SevenFact

Biological Hematology

NDC 71127-5000-1

Open in the dashboard

General payments

$1,558,860

1,987 payments

Research payments

$364,775

59 payments

Through program year 2024, $1,558,860 in general payments and $364,775 in research payments were reported against SevenFact (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2024 General $275,982 427
2024 Research $199,775 24
2023 General $659,484 794
2023 Research $65,000 14
2022 General $369,364 463
2022 Research $90,000 16
2021 General $254,030 303
2021 Research $10,000 5

Breakdown

Who paid General payments · program years 2021–2024
  1. HEMA Biologics, LLC $1,558,860 1,987 payments
Top recipients General payments · program year 2024
  1. Doris Quon Hematology · Los Angeles, CA $40,811 15% · 54 payments
  2. Guy Young Pediatric Hematology-Oncology · Bozeman, MT $36,562 13% · 46 payments
  3. Maissaa Janbain Hematology & Oncology · New Orleans, LA $29,120 11% · 15 payments
  4. Miguel Escobar Hematology · Houston, TX $14,147 5% · 14 payments
  5. Steven Pipe Pediatric Hematology-Oncology · Ann Arbor, MI $13,893 5% · 15 payments

The top 5 of 88 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Pediatric Hematology-Oncology Pediatrics $107,129 40% · 29 practitioners
  2. Hematology & Oncology Internal Medicine $70,371 26% · 15 practitioners
  3. Hematology Internal Medicine $60,191 22% · 6 practitioners
  4. Pediatrics $12,128 4% · 6 practitioners
  5. Internal Medicine $9,203 3% · 3 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $101,828 37% · 7 recipients
  2. Louisiana $29,205 11% · 5 recipients
  3. Michigan $26,149 9% · 6 recipients
  4. North Carolina $24,794 9% · 5 recipients
  5. Texas $15,045 5% · 4 recipients

The top 5 of 26 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

1,987 general · 59 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record